Stocktoria
Canopy Growth Corp CGC
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2010-06-04
Canopy Growth Corp statistics & valuation
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Gross margin | 20.1% | 25.3% | 23.5% | -16.7% | -34.9% |
| Operating margin | -46.6% | -37.3% | -66.5% | -690.0% | -189.5% |
| Net margin | -75.8% | -162.1% | -201.7% | -859.8% | -57.7% |
| FCF margin | -19.9% | -56.2% | -83.0% | -148.6% | -108.4% |
| Return on assets | -23.5% | -55.5% | -53.3% | -134.4% | -5.5% |
| Return on equity | -37.7% | -106.3% | -173.2% | -431.3% | -8.6% |
| Debt / equity | 0.33× | 0.64× | 1.23× | 1.72× | 0.42× |
| Current ratio | 3.34 | 2.86 | 1.11 | 1.34 | 8.10 |
| Revenue growth | 10.5% | -8.7% | -9.8% | -29.1% | -11.5% |
Source: SEC EDGAR filings · CIK 0001737927 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.